Otoprotective effect of recombinant erythropoietin in a model of newborn hypoxic-ischemic encephalopathy


OLGUN Y., KIRKIM G., KOLATAN H. E., KİRAY M., BAĞRIYANIK H. A., Serbetcioglu B., ...More

INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, vol.77, no.5, pp.739-746, 2013 (SCI-Expanded, Scopus)

Abstract

Objective: The aim of this study is to test the hypotheses that central auditory pathology as well as inner ear pathology is contributing mechanisms to observed hypoxic-ischemic encephalopathy (HIE) induced hearing loss and that recombinant erythropoietin (rhEPO) will reduce this cellular pathology and attenuate hearing loss.